Document:

Exhibit 10.1

 

EXECUTION VERSION

 

BIOSCRIP, INC.

 

REGISTRATION RIGHTS AGREEMENT

 

THIS REGISTRATION RIGHTS
AGREEMENT (this “Agreement”) is made as of August 6, 2019 among BioScrip, Inc., a Delaware corporation (the
“Company”), HC Group Holdings I, LLC, a Delaware limited liability company, any each other Person who executes
a Joinder as an “Investor” (collectively, the “Investors”), each Person who executes a Joinder as
an “Executive” (collectively, the “Executives”), and each other Person who executes a Joinder as
an “Other Holder” (collectively, the “Other Holders”).  Except as otherwise specified herein,
all capitalized terms used in this Agreement are defined in Exhibit A attached hereto.

 

In consideration of the
mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
the parties to this Agreement hereby agree as follows:

 

Section 1  Demand
Registrations.

 

(a)  Requests
for Registration. At any time and from time to time, the Majority Holders may request registration under the Securities Act
of all or any portion of their Registrable Securities on Form S-1 or any similar long-form registration (“Long-Form Registrations”)
or on Form S-3 or any similar short-form registration (“Short-Form Registrations”), if available (any
such requested registration, a “Demand Registration”). The Majority Holders may request that any Demand Registration
be made pursuant to Rule 415 under the Securities Act (a “Shelf Registration”) and (if the Company is a WKSI
at the time any such request is submitted to the Company or will become one by the time of the filing of such Shelf Registration)
that such Shelf Registration be an automatic shelf registration statement (as defined in Rule 405 under the Securities Act) (an
“Automatic Shelf Registration Statement”). Each request for a Demand Registration must specify the approximate
number or dollar value of Registrable Securities requested to be registered by the requesting Holders and (if known) the intended
method of distribution. The Majority Holders will be entitled to request an unlimited number of Demand Registrations in which
the Company will pay all Registration Expenses, whether or not any such registration is consummated.

 

(b)  Notice
to Other Holders. Within ten (10) days after receipt of any such request, the Company will give written notice of the Demand
Registration to all other Holders and, subject to the terms of Section 1(e), will include in such Demand Registration (and
in all related registrations and qualifications under state blue sky laws and in any related underwriting) all Registrable Securities
with respect to which the Company has received written requests for inclusion therein within ten (10) days after the receipt of
the Company’s notice; provided that, with the consent of the Majority Holders, the Company may instead provide notice
of the Demand Registration to all other Holders within three (3) Business Days following the non-confidential filing of the registration
statement with respect to the Demand Registration so long as such registration statement is not an Automatic Shelf Registration
Statement.

 

     

     

    

 

(c)  Form
of Registrations. All Long-Form Registrations will be underwritten registrations unless otherwise approved by the Majority
Holders. Demand Registrations will be Short-Form Registrations whenever the Company is permitted to use any applicable short form
and if the managing underwriters (if any) and the Majority Holders agree to the use of a Short-Form Registration.

 

(d)  Shelf
Registrations.

 

(i)        For
so long as a registration statement for a Shelf Registration (a “Shelf Registration Statement”) is and remains
effective, the Majority Holders will have the right at any time or from time to time to elect to sell pursuant to an offering (including
an underwritten offering) Registrable Securities available for sale pursuant to such registration statement (“Shelf Registrable
Securities”). The Majority Holders may elect to sell Registrable Securities pursuant to an underwritten offering by delivering
to the Company a written notice (a “Shelf Offering Notice”) specifying the number of Shelf Registrable Securities
that the holders desire to sell pursuant to such underwritten offering (the “Shelf Offering”). As promptly as
practicable, but in no event later than two (2) Business Days after receipt of a Shelf Offering Notice, the Company will give written
notice of such Shelf Offering Notice to all other Holders of Shelf Registrable Securities that have been identified as selling
stockholders in such Shelf Registration Statement and are otherwise permitted to sell in such Shelf Offering. The Company, subject
to Section 1(e) and Section 7, will include in such Shelf Offering all Shelf Registrable Securities with respect
to which the Company has received written requests for inclusion (which request will specify the maximum number of Shelf Registrable
Securities intended to be disposed of by such Holder) within seven (7) days after the receipt of the Shelf Offering Notice. The
Company will, as expeditiously as possible (and in any event within 20 days after the receipt of a Shelf Offering Notice), but
subject to Section 1(e), use its best efforts to facilitate such Shelf Offering.

 

(ii)        If
the Majority Holders wish to engage in an underwritten block trade or bought deal off of a Shelf Registration Statement (either
through filing an Automatic Shelf Registration Statement or through a take-down from an already existing Shelf Registration Statement)
(an “Underwritten Block Trade”), then notwithstanding the time periods set forth in Section 1(d)(i),
such Majority Holders will notify the Company of the Underwritten Block Trade not less than two (2) Business Days prior to the
day such offering is first anticipated to commence. If requested by the Majority Holders, the Company will promptly notify other
Holders of such Underwritten Block Trade and such notified Holders (each, a “Potential Block Participant”) may
elect whether or not to participate no later than the next Business Day (i.e. one (1) Business Day prior to the day such
offering is to commence) (unless a longer period is agreed to by the Majority Holders), and the Company will as expeditiously as
possible use its best efforts to facilitate such Underwritten Block Trade (which may close as early as two (2) Business Days after
the date it commences); provided further that, notwithstanding the provisions of Section 1(d)(i), no Holder (other
than Holders of Investor Registrable Securities) will be permitted to participate in an Underwritten Block Trade without the consent
of the Majority Holders. Any Potential Block Participant’s request to participate in an Underwritten Block Trade shall be
binding on the Potential Block Participant.

 

    	 	-2-	 

     

    

 

(iii)        All
determinations as to whether to complete any Shelf Offering and as to the timing, manner, price and other terms of any Shelf Offering
contemplated by this Section 1(d) shall be determined by the Majority Holders, and the Company shall use its reasonable
best efforts to cause any Shelf Offering to occur as promptly as practicable.

 

(iv)        The
Company will, at the request of the Majority Holders, file any prospectus supplement or any post-effective amendments and otherwise
take any action necessary to include therein all disclosure and language deemed necessary or advisable by the Majority Holders
to effect such Shelf Offering.

 

(e)  Priority
on Demand Registrations and Shelf Offerings. The Company will not include in any Demand Registration any securities which
are not Registrable Securities without the prior written consent of the Majority Holders. If a Demand Registration or a Shelf
Offering is an underwritten offering and the managing underwriters advise the Company in writing that in their opinion the number
of Registrable Securities and (if permitted hereunder) other securities requested to be included in such offering exceeds the
number of Registrable Securities and other securities (if any), which can be sold therein without adversely affecting the marketability,
proposed offering price, timing or method of distribution of the offering, then the Company will include in such offering (prior
to the inclusion of any securities which are not Registrable Securities): (i) first, the number of Investor Registrable Securities
requested to be included which, in the opinion of such underwriters, can be sold, without any such adverse effect, pro rata among
the respective Holders of Investor Registrable Securities on the basis of the number of Investor Registrable Securities owned
by each such Holder; and (ii) second, the number of Registrable Securities requested to be included by Other Holders which, in
the opinion of such underwriters, can be sold, without any such adverse effect, pro rata among the respective Other Holders on
the basis of the number of Registrable Securities owned by each such Other Holder. In addition, if any Holders of Executive Registrable
Securities have requested to include such securities in an underwritten offering and the managing underwriters for such offering
advise the Company that in their opinion the inclusion of some or all of such Executive Registrable Securities could adversely
affect the marketability, proposed offering price, timing and/or method of distribution of the offering, then the Company shall
exclude from such offering the number of such Executive Registrable Securities identified by the managing underwriters as having
any such adverse effect prior to the exclusion of any Registrable Securities of any other Holders as set forth in this Section
1(e).

 

    	 	-3-	 

     

    

 

(f)  Restrictions
on Demand Registration and Shelf Offerings

 

(i)        The
Company may postpone, for up to 90 days from the date of the request (the “Suspension Period”), the filing or
the effectiveness of a registration statement for a Demand Registration or suspend the use of a prospectus that is part of a Shelf
Registration Statement (and therefore suspend sales of the Shelf Registrable Securities) by providing written notice to the Holders
if the Company determines that the offer or sale of Registrable Securities would reasonably be expected to have a material adverse
effect on any proposal or plan by the Company or any Subsidiary to engage in any material acquisition of assets or stock (other
than in the ordinary course of business) or any material merger, consolidation, tender offer, recapitalization, reorganization,
financing or other transaction involving the Company and upon advice of counsel, the sale of Registrable Securities pursuant to
the registration statement would require disclosure of material non-public information not otherwise required to be disclosed under
applicable law, and (x) the Company has a bona fide business purpose for preserving the confidentiality of such transaction, (y)
disclosure would have a material adverse effect on the Company or the Company’s ability to consummate such transaction, or
(z) such transaction renders the Company unable to comply with SEC requirements, in each case under circumstances that would make
it impractical or inadvisable to cause the registration statement (or such filings) to become effective or to promptly amend or
supplement the registration statement on a post-effective basis, as applicable. The Company may delay or suspend the effectiveness
of a Demand Registration or Shelf Registration Statement pursuant to this Section 1(f)(i) only once in any twelve (12)-month
period (for avoidance of doubt, in addition to the Company’s rights and obligations under Section 4(a)(vi)).

 

(ii)        In
the case of an event that causes the Company to suspend the use of a Shelf Registration Statement as set forth in paragraph (f)(i)
above or pursuant to Section 4(a)(vi) (a “Suspension Event”), the Company will give a notice to the Holders
whose Registrable Securities are registered pursuant to such Shelf Registration Statement (a “Suspension Notice”)
to suspend sales of the Registrable Securities and such notice must state generally the basis for the notice and that such suspension
will continue only for so long as the Suspension Event or its effect is continuing. Each Holder agrees not to effect any sales
of its Registrable Securities pursuant to such Shelf Registration Statement (or such filings) at any time after it has received
a Suspension Notice from the Company and prior to receipt of an End of Suspension Notice. A Holder may recommence effecting sales
of the Registrable Securities pursuant to the Shelf Registration Statement (or such filings) following further written notice to
such effect (an “End of Suspension Notice”) from the Company, which End of Suspension Notice will be given by
the Company to the Holders promptly following the conclusion of any Suspension Event.

 

(g)  Selection
of Underwriters. The Majority Holders will have the right to select the investment banker(s) and manager(s) to administer
any underwritten offering in connection with a Demand Registration or Shelf Offering.

 

(h)  Other
Registration Rights. Except as provided in this Agreement, the Company will not grant to any Person(s) the right to request
the Company or any Subsidiary to register any equity securities of the Company or any Subsidiary, or any securities convertible
or exchangeable into or exercisable for such securities, without the prior written consent of the Majority Holders.

 

(i)  Revocation
of Demand Notice or Shelf Offering Notice. At any time prior to the effective date of the registration statement relating
to a Demand Registration or the “pricing” of any offering relating to a Shelf Offering Notice, the Majority
Holders may revoke such notice of a Demand Registration or Shelf Offering Notice on behalf of all Holders participating in
such Demand Registration or Shelf Offering without liability to such Holders (including, for the avoidance of doubt, the
Majority Holders), in each case by providing written notice to the Company.

 

    	 	-4-	 

     

    

 

(j)  Confidentiality.
Each Holder agrees to treat as confidential the receipt of any notice hereunder (including notice of a Demand Registration, a
Shelf Offering Notice and a Suspension Notice) and the information contained therein, and not to disclose or use the information
contained in any such notice (or the existence thereof) without the prior written consent of the Company until such time as the
information contained therein is or becomes available to the public generally (other than as a result of disclosure by such Holder
in breach of the terms of this Agreement).

 

Section 2  Piggyback
Registrations.

 

(a)  Right
to Piggyback. Whenever the Company proposes to register any of its equity securities under the Securities Act (including primary
and secondary registrations, and other than pursuant to an Excluded Registration) (a “Piggyback Registration”),
the Company will give prompt written notice (and in any event within three (3) Business Days after the public filing of the registration
statement relating to the Piggyback Registration) to all Holders of its intention to effect such Piggyback Registration and, subject
to the terms of Section 2(b) and Section 2(c), will include in such Piggyback Registration (and in all related registrations
or qualifications under blue sky laws and in any related underwriting) all Registrable Securities with respect to which the Company
has received written requests for inclusion therein within ten (10) days after delivery of the Company’s notice; provided
that the Company shall not be required to provide such notice or include any Registrable Securities in such registration if the
Investor elects not to include any Investor Registrable Securities in such registration.

 

(b)  Priority
on Primary Registrations. If a Piggyback Registration is an underwritten primary registration on behalf of the Company, and
the managing underwriters advise the Company in writing that in their opinion the number of securities requested to be included
in such registration exceeds the number which can be sold in such offering without adversely affecting the marketability, proposed
offering price, timing or method of distribution of the offering, the Company will include in such registration (i) first,
the securities the Company proposes to sell, (ii) second, the Investor Registrable Securities requested to be included
in such registration which, in the opinion of the underwriters, can be sold without any such adverse effect, pro rata among the
Holders of Investor Registrable Securities on the basis of the number of Investor Registrable Securities owned by each such Holder,
(iii) third, the Registrable Securities requested to be included in such registration by Other Holders which, in the opinion
of the underwriters, can be sold without any such adverse effect, pro rata among the Other Holders on the basis of the number
of Registrable Securities owned by each such Other Holder, and (iv) fourth, other securities requested to be included in
such registration which, in the opinion of the underwriters, can be sold without any such adverse effect. In addition, if any
Holders of Executive Registrable Securities have requested to include such securities in a Piggyback Registration that is an underwritten
primary offering on behalf of the Company and the managing underwriters for such offering advise the Company in writing that in
their opinion the inclusion of some or all of such Executive Registrable Securities could adversely affect the marketability,
proposed offering price, timing and/or method of distribution of the offering, the Company shall first exclude from such offering
the number (which may be all) of such Executive Registrable Securities identified by the managing underwriters as having any such
adverse effect prior to the exclusion of any securities in such offering.

 

    	 	-5-	 

     

    

 

(c)  Priority
on Secondary Registrations. If a Piggyback Registration is an underwritten secondary registration on behalf of holders of
the Company’s equity securities (other than Majority Holders), and the managing underwriters advise the Company in writing
that in their opinion the number of securities requested to be included in such registration exceeds the number which can be sold
in such offering without adversely affecting the marketability, proposed offering price, timing or method of distribution of the
offering, the Company will include in such registration (i) first, the securities requested to be included therein by the
holders requesting such registration which, in the opinion of the underwriters, can be sold without any such adverse effect, (ii)
second, the Registrable Securities requested to be included in such registration, pro rata among the Holders on the basis
of the number of Registrable Securities owned by each such Holder which, in the opinion of the underwriters, can be sold without
any such adverse effect, and (iii) third, other securities requested to be included in such registration which, in the
opinion of the underwriters, can be sold without any such adverse effect. In addition, if any Holders of Executive Registrable
Securities have requested to include such securities in a Piggyback Registration that is an underwritten secondary offering and
the managing underwriters for such offering advise the Company in writing that in their opinion the inclusion of some or all of
such Executive Registrable Securities could adversely affect the marketability, proposed offering price, timing or method of distribution
of the offering, the Company shall be permitted to first exclude from such offering the number (which may be all) of such Executive
Registrable Securities identified by the managing underwriters as having any such adverse effect prior to the exclusion of any
securities in such offering.

 

(d)  Right
to Terminate Registration. The Company will have the right to terminate or withdraw any registration initiated by it under
this Section 2, whether or not any holder of Registrable Securities has elected to include securities in such registration.

 

(e)  Selection
of Underwriters. If any Piggyback Registration is an underwritten offering, the selection of investment banker(s) and manager(s)
for the offering must be approved by the Majority Holders, which approval shall not be unreasonably withheld, conditioned, or
delayed.

 

Section 3  Stockholder
Lock-Up Agreements and Company Holdback Agreement.

 

(a)  Stockholder
Lock-up Agreements. In connection with any underwritten Public Offering, each Holder will enter into any lock-up, holdback
or similar agreements requested by the underwriter(s) managing such offering, in each case with such modifications and exceptions
as may be approved by the Majority Holders. Without limiting the generality of the foregoing, each Holder hereby agrees that in
connection with any Demand Registration, Shelf Offering or Piggyback Registration that is an underwritten Public Offering, not
to (i) offer, sell, contract to sell, pledge or otherwise dispose of (including sales pursuant to Rule 144), directly or indirectly,
any equity securities of the Company (including equity securities of the Company that may be deemed to be owned beneficially by
such Holder in accordance with the rules and regulations of the SEC) (collectively, “Securities”), or any securities,
options or rights convertible into or exchangeable or exercisable for Securities (collectively, “Other Securities”),
(ii) enter into a transaction which would have the same effect as described in clause (i) above, (iii) enter into any swap, hedge
or other arrangement that transfers, in whole or in part, any of the economic consequences or ownership of any Securities or Other
Securities, whether such transaction is to be settled by delivery of such Securities or Other Securities, in cash or otherwise
(each of (i), (ii) and (iii) above, a “Sale Transaction”), or (iv) publicly disclose the intention to enter
into any Sale Transaction, commencing on the date on which the Company gives notice to the Holders that a preliminary prospectus
has been circulated for such underwritten Public Offering or the “pricing” of such offering and continuing to the
date that is 90 days following the date of the final prospectus (each such period, or such shorter period as agreed to by the
managing underwriters, a “Holdback Period”), in each case with such modifications and exceptions as may be
approved by the Majority Holders. The Company may impose stop-transfer instructions with respect to any Securities or Other Securities
subject to the restrictions set forth in this Section 3(a) until the end of such Holdback Period.

 

    	 	-6-	 

     

    

 

(b)  Company
Holdback Agreement. The Company (i) will not file any registration statement for a Public Offering or cause any such
registration statement to become effective, or effect any public sale or distribution of its Securities or Other Securities during
any Holdback Period (other than as part of such underwritten Public Offering, or a registration on Form S-4 or Form S-8 or any
successor or similar form which is (x) then in effect or (y) shall become effective upon the conversion, exchange or exercise
of any then outstanding Other Securities) and (ii) will cause each holder of Securities and Other Securities (including each of
its directors and executive officers) to agree not to effect any Sale Transaction during any Holdback Period, except as part of
such underwritten registration (if otherwise permitted), unless approved in writing by the Majority Holders and the underwriters
managing the Public Offering and to enter into any lock-up, holdback or similar agreements requested by the underwriter(s) managing
such offering, in each case with such modifications and exceptions as may be approved by the Majority Holders.

 

Section 4  Registration
Procedures.

 

(a)  Company
Obligations. Whenever the holders of Registrable Securities have requested that any Registrable Securities be registered pursuant
to this Agreement or have initiated a Shelf Offering, the Company will use its best efforts to effect the registration and the
sale of such Registrable Securities in accordance with the intended method of disposition thereof, and pursuant thereto the Company
will as expeditiously as possible:

 

(i)        prepare
and file with (or submit confidentially to) the SEC a registration statement, and all amendments and supplements thereto and related
prospectuses, with respect to such Registrable Securities and use its best efforts to cause such registration statement to become
effective, all in accordance with the Securities Act and all applicable rules and regulations promulgated thereunder (provided
that before filing or confidentially submitting a registration statement or prospectus or any amendments or supplements thereto,
the Company will furnish to the counsel selected by the Majority Holders covered by such registration statement copies of all such
documents proposed to be filed or submitted, which documents will be subject to the review and comment of such counsel);

 

    	 	-7-	 

     

    

 

(ii)       notify
each Holder of (A) the issuance by the SEC of any stop order suspending the effectiveness of any registration statement or the
initiation of any proceedings for that purpose, (B) the receipt by the Company or its counsel of any notification with respect
to the suspension of the qualification of the Registrable Securities for sale in any jurisdiction or the initiation or threatening
of any proceeding for such purpose, and (C) the effectiveness of each registration statement filed hereunder;

 

(iii)      prepare
and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection therewith
as may be necessary to keep such registration statement effective for a period ending when all of the securities covered by such
registration statement have been disposed of in accordance with the intended methods of distribution by the sellers thereof set
forth in such registration statement (but not in any event before the expiration of any longer period required under the Securities
Act or, if such registration statement relates to an underwritten Public Offering, such longer period as in the opinion of counsel
for the underwriters a prospectus is required by law to be delivered in connection with sale of Registrable Securities by an underwriter
or dealer) and comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such
registration statement during such period in accordance with the intended methods of disposition by the sellers thereof set forth
in such registration statement;

 

(iv)      furnish,
without charge, to each seller of Registrable Securities thereunder and each underwriter, if any, such number of copies of such
registration statement, each amendment and supplement thereto, the prospectus included in such registration statement (including
each preliminary prospectus) (in each case including all exhibits and documents incorporated by reference therein), each amendment
and supplement thereto, each Free Writing Prospectus and such other documents as such seller or underwriter, if any, may reasonably
request in order to facilitate the disposition of the Registrable Securities owned by such seller (the Company hereby consenting
to the use in accordance with all applicable laws of each such registration statement, each such amendment and supplement thereto,
and each such prospectus (or preliminary prospectus or supplement thereto) or Free Writing Prospectus by each such seller of Registrable
Securities and the underwriters, if any, in connection with the offering and sale of the Registrable Securities covered by such
registration statement or prospectus);

 

(v)       use
its best efforts to register or qualify such Registrable Securities under such other securities or blue sky laws of such jurisdictions
as any seller reasonably requests and do any and all other acts and things which may be reasonably necessary or advisable to enable
such seller to consummate the disposition in such jurisdictions of the Registrable Securities owned by such seller (provided
that the Company will not be required to (A) qualify generally to do business in any jurisdiction where it would not otherwise
be required to qualify but for this subparagraph or (B) consent to general service of process in any such jurisdiction or (C) subject
itself to taxation in any such jurisdiction);

 

    	 	-8-	 

     

    

 

(vi)      notify
in writing each seller of such Registrable Securities (A) promptly after it receives notice thereof, of the date and time
when such registration statement and each post-effective amendment thereto has become effective or a prospectus or supplement to
any prospectus relating to a registration statement has been filed and when any registration or qualification has become effective
under a state securities or blue sky law or any exemption thereunder has been obtained, (B) promptly after receipt thereof,
of any request by the SEC for the amendment or supplementing of such registration statement or prospectus or for additional information,
(C) at any time when a prospectus relating thereto is required to be delivered under the Securities Act, of the happening
of any event or of any information or circumstances as a result of which the prospectus included in such registration statement
contains an untrue statement of a material fact or omits any fact necessary to make the statements therein not misleading, and,
subject to Section 1(f), if required by applicable law or to the extent requested by the Majority Holder, the Company will
use its best efforts to promptly prepare and file a supplement or amendment to such prospectus so that, as thereafter delivered
to the purchasers of such Registrable Securities, such prospectus will not contain an untrue statement of a material fact or omit
to state any fact necessary to make the statements therein not misleading and (D) if at any time the representations and warranties
contemplated by any underwriting agreement, securities sale agreement, or other similar agreement, relating to the offering shall
cease to be true and correct in a manner that would have a material and adverse impact on the Company or the offering;

 

(vii)     (A)
use best efforts to cause all such Registrable Securities to be listed on each securities exchange on which similar securities
issued by the Company are then listed and, if not so listed, to be listed on a securities exchange and, without limiting the generality
of the foregoing, to arrange for at least two market markers to register as such with respect to such Registrable Securities with
FINRA, and (B) comply (and continue to comply) with the requirements of any self-regulatory organization applicable to the Company,
including without limitation all corporate governance requirements;

 

(viii)    use
best efforts to provide a transfer agent and registrar for all such Registrable Securities not later than the effective date of
such registration statement;

 

(ix)      enter
into and perform such customary agreements (including, as applicable, underwriting agreements in customary form) and take all such
other actions as the holders of a majority of the Registrable Securities being sold or the underwriters, if any, reasonably request
in order to expedite or facilitate the disposition of such Registrable Securities (including, without limitation, participating
in “road shows,” investor presentations, marketing events and other selling efforts and effecting a stock or unit split
or combination, recapitalization or reorganization);

 

(x)        make
available for inspection by any seller of Registrable Securities, any underwriter participating in any disposition or sale pursuant
to such registration statement and any attorney, accountant or other agent retained by any such seller or underwriter, all financial
and other records, pertinent corporate and business documents and properties of the Company as will be necessary to enable them
to exercise their due diligence responsibility, and cause the Company’s officers, directors, employees, agents, representatives
and independent accountants to supply all information reasonably requested by any such seller, underwriter, attorney, accountant
or agent in connection with such registration statement and the disposition of such Registrable Securities pursuant thereto;

 

    	 	-9-	 

     

    

 

(xi)      take
all reasonable actions to ensure that any Free-Writing Prospectus utilized in connection with any Demand Registration or Piggyback
Registration or Shelf Offering hereunder complies in all material respects with the Securities Act, is filed in accordance with
the Securities Act to the extent required thereby, is retained in accordance with the Securities Act to the extent required thereby
and, when taken together with the related prospectus, prospectus supplement and related documents, will not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading;

 

(xii)     otherwise
use its best efforts to comply with all applicable rules and regulations of the SEC, and make available to its security holders,
as soon as reasonably practicable, an earnings statement covering the period of at least twelve (12) months beginning with the
first day of the Company’s first full calendar quarter after the effective date of the registration statement, which earnings
statement will satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder;

 

(xiii)    permit
any Holder which, in its sole and exclusive judgment, might be deemed to be an underwriter or a controlling person of the Company,
to participate in the preparation of such registration or comparable statement and to allow such Holder to provide language for
insertion therein, in form and substance satisfactory to the Company, which in the reasonable judgment of such Holder and its counsel
should be included;

 

(xiv)    use
best efforts to prevent the issuance of any stop order suspending the effectiveness of a registration statement, or the issuance
of any order suspending or preventing the use of any related prospectus or suspending the qualification of any Common Stock included
in such registration statement for sale in any jurisdiction, and, in the event any such order is issued, use best efforts to promptly
obtain the withdrawal of such order;

 

(xv)     use
its reasonable best efforts to cause such Registrable Securities covered by such registration statement to be registered with or
approved by such other governmental agencies or authorities as may be necessary to enable the sellers thereof to consummate the
disposition of such Registrable Securities;

 

(xvi)    cooperate
with the Holders covered by the registration statement and the managing underwriter or agent, if any, to facilitate the timely
preparation and delivery of certificates (not bearing any restrictive legends) representing securities to be sold under the registration
statement, or the removal of any restrictive legends associated with any account at which such securities are held, and enable
such securities to be in such denominations and registered in such names as the managing underwriter, or agent, if any, or such
Holders may request;

 

(xvii)   if
requested by any managing underwriter, include in any prospectus or prospectus supplement updated financial or business information
for the Company’s most recent period or current quarterly period (including estimated results or ranges of results) if required
for purposes of marketing the offering in the view of the managing underwriter;

 

    	 	-10-	 

     

    

 

(xviii)  take
no direct or indirect action prohibited by Regulation M under the Exchange Act; provided, however, that to the extent
that any prohibition is applicable to the Company, the Company will take such action as is necessary to make any such prohibition
inapplicable;

 

(xix)     cooperate
with each Holder covered by the registration statement and each underwriter or agent participating in the disposition of such Registrable
Securities and their respective counsel in connection with the preparation and filing of any applications, notices, registrations
and responses to requests for additional information with FINRA, Nasdaq or any other national securities exchange on which the
shares of Common Stock are or are to be listed, and to the extent required by the rules and regulations of FINRA, retain a Qualified
Independent Underwriter acceptable to the managing underwriter;

 

(xx)      in
the case of any underwritten offering, use its best efforts to obtain, and deliver to the underwriter(s), in the manner and to
the extent provided for in the applicable underwriting agreement, one or more cold comfort letters from the Company’s independent
public accountants in customary form and covering such matters of the type customarily covered by cold comfort letters;

 

(xxi)     use
its best efforts to provide (i) on the date that such Registrable Securities are delivered to the underwriters for sale in connection
with a Demand Registration or Shelf Offering, if such securities are being sold through underwriters, or, if such securities are
not being sold through underwriters, on the closing date of the applicable sale, (A) one or more legal opinions of the Company’s
outside counsel, dated such date, in form and substance as customarily given to underwriters in an underwritten public offering
or, in the case of a non-underwritten offering, to the broker, placement agent or other agent of the Holders assisting in the sale
of the Registrable Securities and (B) one or more “negative assurances letters” of the Company’s outside counsel,
dated such date, in form and substance as is customarily given to underwriters in an underwritten public offering or, in the case
of a non-underwritten offering, to the broker, placement agent or other agent of the Holders assisting in the sale of the Registrable
Securities, in each case, addressed to the underwriters, if any, or, if requested, in the case of a non-underwritten offering,
to the broker, placement agent or other agent of the Holders assisting in the sale of the Registrable Securities and (ii) customary
certificates executed by authorized officers of the Company as may be requested by any Holder or any underwriter of such Registrable
Securities;

 

(xxii)    if
the Company files an Automatic Shelf Registration Statement covering any Registrable Securities, use its best efforts to remain
a WKSI (and not become an ineligible issuer (as defined in Rule 405 under the Securities Act)) during the period during which such
Automatic Shelf Registration Statement is required to remain effective;

 

    	 	-11-	 

     

    

 

(xxiii)   if
the Company does not pay the filing fee covering the Registrable Securities at the time an Automatic Shelf Registration Statement
is filed, pay such fee at such time or times as the Registrable Securities are to be sold; and

 

(xxiv)   if
the Automatic Shelf Registration Statement has been outstanding for at least three (3) years, at the end of the third year, refile
a new Automatic Shelf Registration Statement covering the Registrable Securities, and, if at any time when the Company is required
to re-evaluate its WKSI status the Company determines that it is not a WKSI, use its best efforts to refile the Shelf Registration
Statement on Form S-3 and, if such form is not available, Form S-1 and keep such registration statement effective during the period
during which such registration statement is required to be kept effective.

 

(b)  Holder
Obligations.

 

(i)        It is
agreed and understood that it shall be a condition precedent to the obligations of the Company to complete the registration pursuant
to this Agreement with respect to the Registrable Securities of a particular Holder that (A) such Holder furnish to the Company
such information regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable
Securities held by it as shall be reasonably required to effect the effectiveness of the registration of such Registrable Securities,
and (B) such Holder execute such documents in connection with such registration as the Company may reasonably request, including,
without limitation, a waiver of its registration rights hereunder to the extent a Holder elects not to have any of its Registrable
Securities included in a particular registration statement.

 

(ii)       Each
Holder, by its acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by the Company
in connection with the preparation and filing of a registration statement hereunder, unless such Holder has notified the Company
in writing of its election to exclude all of its Registrable Securities from such registration statement.

 

(iii)      Each
Holder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable to
it or an exemption therefrom in connection with sales of Registrable Securities pursuant to any registration statement.

 

(c)  Automatic
Shelf Registration Statements. If the Company files any Automatic Shelf Registration Statement for the benefit of the holders
of any of its securities other than the Holders, and the Holders of Investor Registrable Securities do not request that their
Registrable Securities be included in such Shelf Registration Statement, the Company agrees that, at the request of the Majority
Holders, it will include in such Automatic Shelf Registration Statement such disclosures as may be required by Rule 430B in order
to ensure that the Holders of Investor Registrable Securities may be added to such Shelf Registration Statement at a later time
through the filing of a prospectus supplement rather than a post-effective amendment. If the Company has filed any Automatic Shelf
Registration Statement for the benefit of the holders of any of its securities other than the Holders, the Company shall, at the
request of the Majority Holders, file any post-effective amendments necessary to include therein all disclosure and language necessary
to ensure that the holders of Registrable Securities may be added to such Shelf Registration Statement.

 

    	 	-12-	 

     

    

 

(d)  Additional
Information. The Company may require each seller of Registrable Securities as to which any registration is being effected
to furnish the Company such information regarding such seller and the distribution of such securities as the Company may from
time to time reasonably request in writing, as a condition to such seller’s participation in such registration.

 

(e)  In-Kind
Distributions. If an Investor (and/or any of their Affiliates) seek to effectuate an in-kind distribution of all or part of
their Registrable Securities to their respective direct or indirect equityholders, the Company will, subject to any applicable
lock-ups, work with the foregoing Persons to facilitate such in-kind distribution in the manner reasonably requested and consistent
with the Company’s obligations under the Securities Act.

 

(f)  Suspended
Distributions. Each Person participating in a registration hereunder agrees that, upon receipt of any notice from the Company
of the happening of any event of the kind described in Section 4(a)(vi), such Person will immediately discontinue the disposition
of its Registrable Securities pursuant to the registration statement until such Person’s receipt of the copies of a supplemented
or amended prospectus as contemplated by Section 4(a)(vi), subject to the Company’s compliance with its obligations
under Section 4(a)(vi).

 

(g)  Other.  To
the extent that any of the Investors is or may be deemed to be an “underwriter” of Registrable Securities pursuant
to any SEC comments or policies, the Company agrees that (i) the indemnification and contribution provisions contained in Section
6 shall be applicable to the benefit of such Investor in their role as an underwriter or deemed underwriter in addition to their
capacity as a holder and (ii) such Investor shall be entitled to conduct the due diligence which they would normally conduct in
connection with an offering of securities registered under the Securities Act, including without limitation receipt of customary
opinions and comfort letters addressed to such Investor.

 

    	 	-13-	 

     

    

 

Section 5  Registration
Expenses.

 

Except as expressly
provided herein, all out-of-pocket expenses incurred by the Company or any Investor and their respective Affiliates in connection
with the performance of or compliance with this Agreement and/or in connection with any Demand Registration, Piggyback Registration
or Shelf Offering, whether or not the same shall become effective, shall be paid by the Company, including, without limitation,
(i) all registration and filing fees, and any other fees and expenses associated with filings required to be made with the SEC
or FINRA, (ii) all fees and expenses in connection with compliance with any securities or “blue sky” laws, (iii) all
printing, duplicating, word processing, messenger, telephone, facsimile and delivery expenses (including expenses of printing
certificates for the Registrable Securities in a form eligible for deposit with The Depository Trust Company or other depositary
and of printing prospectuses and Company Free Writing Prospectuses), (iv) all fees and disbursements of counsel for the Company
and of all independent certified public accountants of the Company (including the expenses of any special audit and cold comfort
letters required by or incident to such performance), (v) Securities Act liability insurance or similar insurance if the Company
so desires or the underwriters so require in accordance with then-customary underwriting practice, (vi) all fees and expenses
incurred in connection with the listing of the Registrable Securities on any securities exchange on which similar securities of
the Company are then listed, (vii) all applicable rating agency fees with respect to the Registrable Securities, (viii) all reasonable
fees and disbursements of one legal counsel for selling Holders selected by the Majority Holders together with any necessary local
counsel as may be required by the Investors, (ix) any fees and disbursements of underwriters customarily paid by issuers or sellers
of securities, (x) all fees and expenses of any special experts or other Persons retained by the Company or the Investors in connection
with any registration statement (xi) all of the Company’s internal expenses (including all salaries and expenses of its
officers and employees performing legal or accounting duties) and (xii) all expenses related to the “road-show” for
any underwritten offering, including all travel, meals and lodging. All such expenses are referred to herein as “Registration
Expenses.” The Company shall not be required to pay, and each Person that sells securities pursuant to a Demand Registration,
Shelf Offering or Piggyback Registration hereunder will bear and pay, all underwriting discounts and commissions applicable to
the Registrable Securities sold for such Person’s account and all transfer taxes (if any) attributable to the sale of Registrable
Securities.

 

Section 6  Indemnification
and Contribution.

 

(a)  By
the Company. The Company will indemnify and hold harmless, to the fullest extent permitted by law and without limitation as
to time, each Holder, such Holder’s officers, directors employees, agents, fiduciaries, stockholders, partners, members,
affiliates, consultants and representatives, and any successors and assigns thereof, and each Person who controls such holder
(within the meaning of the Securities Act) (the “Indemnified Parties”) against all losses, claims, actions,
damages, liabilities and expenses (including with respect to actions or proceedings, whether commenced or threatened, and including
reasonable attorney fees and expenses) (collectively, “Losses”) caused by, resulting from, arising out of,
based upon or related to any of the following (each, a “Violation”) by the Company: (i) any untrue or
alleged untrue statement of material fact contained in (A) any registration statement, prospectus, preliminary prospectus or Free-Writing
Prospectus, or any amendment thereof or supplement thereto or (B) any application or other document or communication (in this
Section 6, collectively called an “application”) executed by or on behalf of the Company or based upon
written information furnished by or on behalf of the Company filed in any jurisdiction in order to qualify any securities covered
by such registration under the “blue sky” or securities laws thereof, (ii) any omission or alleged omission of
a material fact required to be stated therein or necessary to make the statements therein not misleading or (iii) any violation
or alleged violation by the Company of the Securities Act or any other similar federal or state securities laws or any rule or
regulation promulgated thereunder applicable to the Company and relating to action or inaction required of the Company in connection
with any such registration, qualification or compliance. In addition, the Company will reimburse such Indemnified Party for any
legal or any other expenses reasonably incurred by them in connection with investigating or defending any such Losses. Notwithstanding
the foregoing, the Company will not be liable in any such case to the extent that any such Losses result from, arise out of, are
based upon, or relate to an untrue statement, or omission, made in such registration statement, any such prospectus, preliminary
prospectus or Free-Writing Prospectus or any amendment or supplement thereto, or in any application, in reliance upon, and in
conformity with, written information prepared and furnished in writing to the Company by such Indemnified Party expressly for
use therein or by such Indemnified Party’s failure to deliver a copy of the registration statement or prospectus or any
amendments or supplements thereto after the Company has furnished such Indemnified Party with a sufficient number of copies of
the same. In connection with an underwritten offering, the Company will indemnify such underwriters, their officers and directors,
and each Person who controls such underwriters (within the meaning of the Securities Act) to the same extent as provided above
with respect to the indemnification of the Indemnified Parties or as otherwise agreed to in the underwriting agreement executed
in connection with such underwritten offering. Such indemnity and reimbursement of expenses shall remain in full force and effect
regardless of any investigation made by or on behalf of such Indemnified Party and shall survive the transfer of such securities
by such seller.

 

    	 	-14-	 

     

    

 

(b)  By
Holders. In connection with any registration statement in which a Holder is participating, each such Holder will furnish to
the Company in writing such information and affidavits as the Company reasonably requests for use in connection with any such
registration statement or prospectus and, to the extent permitted by law, will indemnify the Company, its officers, directors,
employees, agents and representatives, and each Person who controls the Company (within the meaning of the Securities Act) against
any Losses caused by, resulting from, arising out of, based upon or related to any untrue statement of material fact contained
in the registration statement, prospectus or preliminary prospectus or any amendment thereof or supplement thereto or any omission
of a material fact required to be stated therein or necessary to make the statements therein not misleading, but only to the extent
that such untrue statement or omission is contained in any information or affidavit so furnished in writing by such Holder expressly
for use therein; provided that the obligation to indemnify will be individual, not joint and several, for each holder and
will be limited to the net amount of proceeds received by such Holder from the sale of Registrable Securities pursuant to such
registration statement.

 

(c)  Claim
Procedure. Any Person entitled to indemnification hereunder will (i) give prompt written notice to the indemnifying party
of any claim with respect to which it seeks indemnification (provided that the failure to give prompt notice will impair
any Person’s right to indemnification hereunder only to the extent such failure has prejudiced the indemnifying party) and
(ii) unless in such indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying
parties may exist with respect to such claim, permit such indemnifying party to assume the defense of such claim with counsel
reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party will not be subject to any
liability for any settlement made by the indemnified party without its consent (but such consent will not be unreasonably withheld,
conditioned or delayed). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim will not
be obligated to pay the fees and expenses of more than one counsel for all parties indemnified by such indemnifying party with
respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may exist between such
indemnified party and any other of such indemnified parties with respect to such claim. In such instance, the conflicted indemnified
parties will have a right to retain one separate counsel, chosen by the Majority Holders, at the expense of the indemnifying party.

 

    	 	-15-	 

     

    

 

(d)  Contribution.
If the indemnification provided for in this Section 6 is held by a court of competent jurisdiction to be unavailable to,
or is insufficient to hold harmless, an indemnified party or is otherwise unenforceable with respect to any Loss referred to herein,
then such indemnifying party will contribute to the amounts paid or payable by such indemnified party as a result of such Loss,
(i) in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and of the indemnified
party on the other hand in connection with the statements or omissions which resulted in such Loss as well as any other relevant
equitable considerations or (ii) if the allocation provided by clause (i) of this Section 6(d) is not permitted by applicable
law, then in such proportion as is appropriate to reflect not only such relative fault but also the relative benefit of the Company
on the one hand and of the sellers of Registrable Securities and any other sellers participating in the registration statement
on the other in connection with the statement or omissions which resulted in such Losses, as well as any other relevant equitable
considerations; provided that the maximum amount of liability in respect of such contribution will be limited, in the case
of each seller of Registrable Securities, to an amount equal to the net proceeds actually received by such seller from the sale
of Registrable Securities effected pursuant to such registration. The relative fault of the indemnifying party and of the indemnified
party will be determined by reference to, among other things, whether the untrue (or, as applicable alleged) untrue statement
of a material fact or the omission to state a material fact relates to information supplied by the indemnifying party or by the
indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent
such statement or omission. The parties hereto agree that it would not be just or equitable if the contribution pursuant to this
Section 6(d) were to be determined by pro rata allocation or by any other method of allocation that does not take into
account such equitable considerations. The amount paid or payable by an indemnified party as a result of the Losses referred to
herein will be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with
investigating or defending against any action or claim which is the subject hereof. No person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any Person who is not guilty
of such fraudulent misrepresentation.

 

(e)  Release.
No indemnifying party will, except with the consent of the indemnified party, consent to the entry of any judgment or enter into
any settlement that does not include as an unconditional term thereof giving by the claimant or plaintiff to such indemnified
party of a release from all liability in respect to such claim or litigation.

 

(f)  Non-exclusive
Remedy; Survival. The indemnification and contribution provided for under this Agreement will be in addition to any other
rights to indemnification or contribution that any indemnified party may have pursuant to law or contract (and the Company and
its Subsidiaries shall be considered the indemnitors of first resort in all such circumstances to which this Section 6
applies) and will remain in full force and effect regardless of any investigation made by or on behalf of the indemnified party
or any officer, director or controlling Person of such indemnified party and will survive the transfer of Registrable Securities
and the termination or expiration of this Agreement.

 

    	 	-16-	 

     

    

 

Section
7      Cooperation with Underwritten Offerings. No Person may participate in any underwritten
registration hereunder unless such Person (i) agrees to sell such Person’s securities on the basis provided in any underwriting
arrangements approved by the Person or Persons entitled hereunder to approve such arrangements (including, without limitation,
pursuant to the terms of any over-allotment or “green shoe” option requested by the underwriters; provided
that no Holder will be required to sell more than the number of Registrable Securities such Holder has requested to include in
such registration) and (ii) completes, executes and delivers all questionnaires, powers of attorney, stock powers, custody agreements,
indemnities, underwriting agreements and other documents and agreements required under the terms of such underwriting arrangements
or as may be reasonably requested by the Company and the lead managing underwriter(s). To the extent that any such agreement is
entered into pursuant to, and consistent with, Section 3, Section 4 and/or this Section 7, the respective
rights and obligations created under such agreement will supersede the respective rights and obligations of the Holders, the Company
and the underwriters created thereby with respect to such registration.

 

Section 8      Subsidiary
Public Offering. If, after an initial Public Offering of the common equity securities of one of its Subsidiaries, the Company
distributes securities of such Subsidiary to its equityholders, then the rights and obligations of the Company pursuant to this
Agreement will apply, mutatis mutandis, to such Subsidiary, and the Company will cause such Subsidiary to comply with such
Subsidiary’s obligations under this Agreement as if it were the Company hereunder.

 

Section 9       Joinder.
The Company may from time to time (with the prior written consent of the Majority Holders) permit any Person who acquires Common
Equity (or rights to acquire Common Equity) to become a party to this Agreement and to be entitled to and be bound by all of the
rights and obligations as a Holder by obtaining an executed joinder to this Agreement from such Person in the form of Exhibit B
attached hereto (a “Joinder”). In addition, any transferee of Registrable Securities shall (with the prior
written consent of the Majority Holders) be permitted to become a party to this Agreement and to be entitled to and be bound by
all of the rights and obligations as a Holder by obtaining an executed Joinder. Upon the execution and delivery of a Joinder by
such Person, the Common Equity held by such Person shall become the category of Registrable Securities (i.e. Investor, Executive
or Other Holder Registrable Securities), and such Person shall be deemed the category of Holder (i.e. Investor, Executive or Other
Holder), in each case as set forth on the signature page to such Joinder.

 

    	 	-17-	 

     

    

 

Section 10  General
Provisions.

 

(a)  Amendments
and Waivers. Except as otherwise provided herein, the provisions of this Agreement may be amended, modified or waived only
with the prior written consent of the Company and the Majority Holders. The failure or delay of any Person to enforce any of the
provisions of this Agreement will in no way be construed as a waiver of such provisions and will not affect the right of such
Person thereafter to enforce each and every provision of this Agreement in accordance with its terms. A waiver or consent to or
of any breach or default by any Person in the performance by that Person of his, her or its obligations under this Agreement will
not be deemed to be a consent or waiver to or of any other breach or default in the performance by that Person of the same or
any other obligations of that Person under this Agreement.

 

(b)  Remedies.
The parties to this Agreement will be entitled to enforce their rights under this Agreement specifically (without posting a bond
or other security), to recover damages caused by reason of any breach of any provision of this Agreement and to exercise all other
rights existing in their favor. The parties hereto agree and acknowledge that a breach of this Agreement would cause irreparable
harm and money damages would not be an adequate remedy for any such breach and that, in addition to any other rights and remedies
existing hereunder, any party will be entitled to specific performance and/or other injunctive relief from any court of law or
equity of competent jurisdiction (without posting any bond or other security) in order to enforce or prevent violation of the
provisions of this Agreement.

 

(c)  Severability.
Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Agreement is held to be prohibited, invalid, illegal or unenforceable in any respect under any
applicable law or regulation in any jurisdiction, such prohibition, invalidity, illegality or unenforceability will not affect
the validity, legality or enforceability of any other provision of this Agreement in such jurisdiction or in any other jurisdiction,
but this Agreement will be reformed, construed and enforced in such jurisdiction as if such prohibited, invalid, illegal or unenforceable
provision had never been contained herein.

 

(d)  Entire
Agreement. Except as otherwise provided herein, this Agreement contains the complete agreement and understanding among the
parties hereto with respect to the subject matter hereof and supersedes and preempts any prior understandings, agreements or representations
by or among the parties hereto, written or oral, which may have related to the subject matter hereof in any way.

 

(e)  Successors
and Assigns. Except as otherwise provided herein, this Agreement will bind and inure to the benefit and be enforceable by
the Company and its successors and permitted assigns and the Holders and their respective successors and permitted assigns (whether
so expressed or not).

 

(f)  Notices.
Any notice, demand or other communication to be given under or by reason of the provisions of this Agreement will be in writing
and will be deemed to have been given (i) when delivered personally to the recipient, (ii) when sent by confirmed electronic
mail or facsimile if sent during normal business hours of the recipient; but if not, then on the next Business Day, (iii) one
Business Day after it is sent to the recipient by reputable overnight courier service (charges prepaid) or (iv) three Business
Days after it is mailed to the recipient by first class mail, return receipt requested. Such notices, demands and other communications
will be sent to the Company at the address specified on the signature page hereto or any Joinder and to any holder, or at such
address or to the attention of such other Person as the recipient party has specified by prior written notice to the sending party.
Any party may change such party’s address for receipt of notice by giving prior written notice of the change to the sending
party as provided herein. The Company’s address is:

 

    	 	-18-	 

     

    

 

BioScrip, Inc.

1600 Broadway, Suite 700

Denver, CO 80202

Attention: General Counsel

 

With a copy to:

 

Kirkland & Ellis LLP

300 N. LaSalle

Chicago, IL 60654

Attention: Sanford E. Perl, P.C.

   Mark A. Fennell, P.C.

 

or to such other address or to the attention
of such other person as the recipient party has specified by prior written notice to the sending party.

 

(g)  Business
Days. If any time period for giving notice or taking action hereunder expires on a day that is not a Business Day, the time
period will automatically be extended to the Business Day immediately following such Saturday, Sunday or legal holiday.

 

(h)  Governing
Law. All issues and questions concerning the construction, validity, interpretation and enforcement of this Agreement and
the exhibits and schedules hereto will be governed by, and construed in accordance with, the laws of the State of Delaware, without
giving effect to any choice of law or conflict of law rules or provisions (whether of the State of Delaware or any other jurisdiction)
that would cause the application of the laws of any jurisdiction other than the State of Delaware. In furtherance of the foregoing,
the internal law of the State of Delaware will control the interpretation and construction of this Agreement (and all schedules
and exhibits hereto), even though under that jurisdiction’s choice of law or conflict of law analysis, the substantive law
of some other jurisdiction would ordinarily apply.

 

(i)  MUTUAL
WAIVER OF JURY TRIAL. AS A SPECIFICALLY BARGAINED FOR INDUCEMENT FOR EACH OF THE PARTIES HERETO TO ENTER INTO THIS AGREEMENT
(AFTER HAVING THE OPPORTUNITY TO CONSULT WITH COUNSEL), EACH PARTY HERETO EXPRESSLY WAIVES THE RIGHT TO TRIAL BY JURY IN ANY LAWSUIT
OR PROCEEDING RELATING TO OR ARISING IN ANY WAY FROM THIS AGREEMENT OR THE MATTERS CONTEMPLATED HEREBY.

 

    	 	-19-	 

     

    

 

(j)  CONSENT
TO JURISDICTION AND SERVICE OF PROCESS. EACH OF THE PARTIES IRREVOCABLY SUBMITS TO THE NON-EXCLUSIVE JURISDICTION OF THE UNITED
STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE, FOR THE PURPOSES OF ANY SUIT, ACTION OR OTHER PROCEEDING ARISING OUT OF THIS
AGREEMENT, ANY RELATED AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY OR THEREBY. EACH OF THE PARTIES HERETO FURTHER AGREES
THAT SERVICE OF ANY PROCESS, SUMMONS, NOTICE OR DOCUMENT BY U.S. REGISTERED MAIL TO SUCH PARTY’S RESPECTIVE ADDRESS SET
FORTH ABOVE WILL BE EFFECTIVE SERVICE OF PROCESS FOR ANY ACTION, SUIT OR PROCEEDING WITH RESPECT TO ANY MATTERS TO WHICH IT HAS
SUBMITTED TO JURISDICTION IN THIS PARAGRAPH. EACH OF THE PARTIES HERETO IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY OBJECTION TO
THE LAYING OF VENUE OF ANY ACTION, SUIT OR PROCEEDING ARISING OUT OF THIS AGREEMENT, ANY RELATED DOCUMENT OR THE TRANSACTIONS
CONTEMPLATED HEREBY AND THEREBY IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE, AND HEREBY AND THEREBY FURTHER
IRREVOCABLY AND UNCONDITIONALLY WAIVES AND AGREES NOT TO PLEAD OR CLAIM IN ANY SUCH COURT THAT ANY SUCH ACTION, SUIT OR PROCEEDING
BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.

 

(k)  No
Recourse. Notwithstanding anything to the contrary in this Agreement, the Company and each Holder agrees and acknowledges
that no recourse under this Agreement or any documents or instruments delivered in connection with this Agreement, will be had
against any current or future director, officer, employee, general or limited partner or member of any Holder or any Affiliate
or assignee thereof, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any
statute, regulation or other applicable law, it being expressly agreed and acknowledged that no personal liability whatsoever
will attach to, be imposed on or otherwise be incurred by any current or future officer, agent or employee of any Holder or any
current or future member of any Holder or any current or future director, officer, employee, partner or member of any Holder or
of any Affiliate or assignee thereof, as such for any obligation of any Holder under this Agreement or any documents or instruments
delivered in connection with this Agreement for any claim based on, in respect of or by reason of such obligations or their creation.

 

(l)  Descriptive
Headings; Interpretation. The descriptive headings of this Agreement are inserted for convenience only and do not constitute
a part of this Agreement. The use of the word “including” in this Agreement will be by way of example rather than
by limitation.

 

(m)  No
Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties hereto to
express their mutual intent, and no rule of strict construction will be applied against any party.

 

(n)  Counterparts.
This Agreement may be executed in multiple counterparts, any one of which need not contain the signature of more than one party,
but all such counterparts taken together will constitute one and the same agreement.

 

    	 	-20-	 

     

    

 

(o)  Electronic
Delivery. This Agreement, the agreements referred to herein, and each other agreement or instrument entered into in connection
herewith or therewith or contemplated hereby or thereby, and any amendments hereto or thereto, to the extent executed and delivered
by means of a photographic, photostatic, facsimile or similar reproduction of such signed writing using a facsimile machine or
electronic mail will be treated in all manner and respects as an original agreement or instrument and will be considered to have
the same binding legal effect as if it were the original signed version thereof delivered in person. At the request of any party
hereto or to any such agreement or instrument, each other party hereto or thereto will re-execute original forms thereof and deliver
them to all other parties. No party hereto or to any such agreement or instrument will raise the use of a facsimile machine or
electronic mail to deliver a signature or the fact that any signature or agreement or instrument was transmitted or communicated
through the use of a facsimile machine or electronic mail as a defense to the formation or enforceability of a contract and each
such party forever waives any such defense.

 

(p)  Further
Assurances. In connection with this Agreement and the transactions contemplated hereby, each Holder agrees to execute and
deliver any additional documents and instruments and perform any additional acts that may be necessary or appropriate to effectuate
and perform the provisions of this Agreement and the transactions contemplated hereby.

 

(q)  
Effective Date. This Agreement will become effective only upon the issuance of the Common Equity upon consummation
of the closing under the Merger Agreement. However, prior thereto, this Agreement will terminate and become null and void automatically
without any further action by any of the parties hereto immediately upon the termination of the Merger Agreement pursuant to its
terms.

 

(r)  Dividends,
Recapitalizations, Etc.. If at any time or from time to time there is any change in the capital structure of the Company by
way of a stock split, stock dividend, combination or reclassification, or through a merger, consolidation, reorganization or recapitalization,
or by any other means, appropriate adjustment will be made in the provisions hereof so that the rights and privileges granted
hereby will continue.

 

(s)  No
Third-Party Beneficiaries. No term or provision of this Agreement is intended to be, or shall be, for the benefit of any Person
not a party hereto, and no such other Person shall have any right or cause of action hereunder, except as otherwise expressly
provided herein.

 

(t)  Current
Public Information. The Company will at all times file all reports required to be filed by it under the Securities Act and
the Exchange Act and will take such further action as the Majority Holders may reasonably request, all to the extent required
to enable such Holders to sell Registrable Securities (or securities that would be Registrable Securities but for the final sentence
of the definition of Registrable Securities) pursuant to Rule 144.

 

*    
*     *      *     * 

 

    	 	-21-	 

     

    

 

IN WITNESS WHEREOF, the
parties have executed this Registration Rights Agreement as of the date first written above.

 

	 	BIOSCRIP, INC.
	 	 	 
	 	By:	/s/ Daniel E. Greenleaf
	 	 	 
	 	Its:	President
	 	 	 
	 	INVESTOR:
	 	 
	 	HC GROUP HOLDINGS I, LLC
	 	 	 
	 	By:	/s/ Clifford Berman
	 	 	Clifford Berman
	 	Its:	Corporate Secretary
	 	Address:  	3000 Lakeside Dr. #300n,
	 	 	Bannockburn, IL 60015

 

     

     

    

  

EXHIBIT A

 

DEFINITIONS

 

Capitalized terms used
in this Agreement have the meanings set forth below.

 

“Affiliate”
of any Person means any other Person controlled by, controlling or under common control with such Person and, in the case of an
individual, also includes any member of such individual’s Family Group; provided that the Company and its Subsidiaries
will not be deemed to be Affiliates of any holder of Registrable Securities. As used in this definition, “control”
(including, with its correlative meanings, “controlling,” “controlled by” and “under common control
with”) will mean possession, directly or indirectly, of power to direct or cause the direction of management or policies
(whether through ownership of securities, by contract or otherwise).

 

“Agreement”
has the meaning set forth in the recitals.

 

“Automatic Shelf
Registration Statement” has the meaning set forth in Section 1(a).

 

“Business Day”
means any day that is not a Saturday, a Sunday or other day on which banks are required or authorized by Law to be closed in the
State of New York.

 

“Common Equity”
means the Company’s common stock, par value $0.0001 per share.

 

“Company”
has the meaning set forth in the preamble and shall include its successor(s).

 

“Demand Registrations”
has the meaning set forth in Section 1(a).

 

“End of Suspension
Notice” has the meaning set forth in Section 1(f)(ii).

 

“Exchange Act”
means the Securities Exchange Act of 1934, as amended from time to time, or any successor federal law then in force, together with
all rules and regulations promulgated thereunder.

 

“Excluded Registration”
means any registration (i) pursuant to a Demand Registration (which is addressed in Section 1(a)) or (ii) in connection
with registrations on Form S-4 or S-8 promulgated by the SEC (or any successor or similar forms).

 

“Executives”
has the meaning set forth in the recitals.

 

“Executive Registrable
Securities” means any Common Equity held by Executives party to a Joinder.

 

    	 	A-1	 

     

    

 

“Family Group”
means, means with respect to any individual, such individual’s current or former spouse, their respective parents, descendants
of such parents (whether natural or adopted) and the spouses of such descendants, any any trust, limited partnership, corporation
or limited liability company established solely for the benefit of such individual or such individual’s current or former
spouse, their respective parents, descendants of such parents (whether natural or adopted) or the spouses of such descendants.

 

“FINRA”
means the Financial Industry Regulatory Authority.

 

“Free Writing
Prospectus” means a free-writing prospectus, as defined in Rule 405.

 

“Holdback Period”
has the meaning set forth in Section 3(a).

 

“Holder”
means a holder of Registrable Securities who is a party to this Agreement (including by way of Joinder).

 

“Indemnified
Parties” has the meaning set forth in Section 6(a).

 

“Investors”
has the meaning set forth in the recitals.

 

“Investor Registrable
Securities” means (i) any Common Equity held (directly or indirectly) by an Investor or any of its Affiliates, and (ii)
any equity securities of the Company or any Subsidiary issued or issuable with respect to the securities referred to in clause
(i) above by way of dividend, distribution, split or combination of securities, or any recapitalization, merger, consolidation
or other reorganization.

 

“Joinder”
has the meaning set forth in Section 9.

 

“Long-Form Registrations”
has the meaning set forth in Section 1(a).

 

“Losses”
has the meaning set forth in Section 6(c).

 

“Majority Holders”
means the holders of a majority of the aggregate Investor Registrable Securities.

 

“Merger Agreement”
means the Agreement and Plan of Merger dated as of March 14, 2019, by and among the Company, Beta Sub, Inc., a Delaware corporation
and a wholly-owned Subsidiary of the Company, Beta Sub, LLC, a Delaware limited liability company and a wholly-owned Subsidiary
of Beta, HC Group Holdings I, LLC, a Delaware limited liability company, HC Group Holdings II, Inc., a Delaware corporation and
a wholly-owned subsidiary of HC Group Holdings I, LLC, and HC Group Holdings III, Inc., a Delaware corporation and a wholly-owned
subsidiary of HC Group Holdings II, LLC, as amended or modified.

 

“Other Holders”
has the meaning set forth in the recitals.

 

“Other Registrable
Securities” means (i) any Common Equity held (directly or indirectly) by any Other Holders or any of their Affiliates,
and (ii) any equity securities of the Company or any Subsidiary issued or issuable with respect to the securities referred to in
clause (i) above by way of dividend, distribution, split or combination of securities, or any recapitalization, merger,
consolidation or other reorganization.

 

    	 	A-2	 

     

    

 

“Person”
means an individual, a partnership, a corporation, a limited liability company, an association, a joint stock company, a trust,
a joint venture, an unincorporated organization and a governmental entity or any department, agency or political subdivision thereof.

 

“Piggyback Registrations”
has the meaning set forth in Section 2(a).

 

“Public Offering”
means any sale or distribution by the Company, one of its Subsidiaries and/or Holders to the public of Common Equity or other securities
convertible into or exchangeable for Common Equity pursuant to an offering registered under the Securities Act.

 

“Registrable
Securities” means Investor Registrable Securities and Executive Registrable Securities and Other Registrable Securities.
As to any particular Registrable Securities, such securities will cease to be Registrable Securities when they have been (a) sold
or distributed pursuant to a Public Offering, (b) sold in compliance with Rule 144, or (c) repurchased by the Company or a
Subsidiary of the Company. For purposes of this Agreement, a Person will be deemed to be a holder of Registrable Securities, and
the Registrable Securities will be deemed to be in existence, whenever such Person has the right to acquire, directly or indirectly,
such Registrable Securities (upon conversion or exercise in connection with a transfer of securities or otherwise, but disregarding
any restrictions or limitations upon the exercise of such right), whether or not such acquisition has actually been effected, and
such Person will be entitled to exercise the rights of a holder of Registrable Securities hereunder (it being understood that a
holder of Registrable Securities may only request that Registrable Securities in the form of Common Equity be registered pursuant
to this Agreement). Notwithstanding the foregoing, any Registrable Securities held by any Person (other than an Investor or its
Affiliates) that may be sold under Rule 144(b)(1)(i) without limitation under any of the other requirements of Rule 144 will not
be deemed to be Registrable Securities.

 

“Registration
Expenses” has the meaning set forth in Section 5.

 

“Rule 144”,
“Rule 158”, “Rule 405”, “Rule 415”, “Rule 430B” and
“Rule 462” mean, in each case, such rule promulgated under the Securities Act (or any successor provision) by
the SEC, as the same will be amended from time to time, or any successor rule then in force.

 

“Sale Transaction”
has the meaning set forth in Section 3(a).

 

“SEC”
means the United States Securities and Exchange Commission.

 

“Securities”
has the meaning set forth in Section 3(a).

 

“Securities
Act” means the Securities Act of 1933, as amended from time to time, or any successor federal law then in force, together
with all rules and regulations promulgated thereunder.

 

“Shelf Offering”
has the meaning set forth in Section 1(d)(i).

 

    	 	A-3	 

     

    

 

“Shelf Offering
Notice” has the meaning set forth in Section 1(d)(i).

 

“Shelf Registration”
has the meaning set forth in Section 1(a).

 

“Shelf Registrable
Securities” has the meaning set forth in Section 1(d)(i).

 

“Shelf Registration
Statement” has the meaning set forth in Section 1(d).

 

“Short-Form
Registrations” has the meaning set forth in Section 1(a).

 

“Subsidiary”
means, with respect to the Company, any corporation, limited liability company, partnership, association or other business entity
of which (i) if a corporation, a majority of the total voting power of shares of stock entitled (without regard to the occurrence
of any contingency) to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly
or indirectly, by the Company or one or more of the other Subsidiaries of the Company or a combination thereof, or (ii) if a limited
liability company, partnership, association or other business entity, a majority of the limited liability company, partnership
or other similar ownership interest thereof is at the time owned or controlled, directly or indirectly, by the Company or one or
more Subsidiaries of the Company or a combination thereof. For purposes hereof, a Person or Persons will be deemed to have a majority
ownership interest in a limited liability company, partnership, association or other business entity if such Person or Persons
will be allocated a majority of limited liability company, partnership, association or other business entity gains or losses or
will be or control the managing director or general partner of such limited liability company, partnership, association or other
business entity.

 

“Suspension
Event” has the meaning set forth in Section 1(f)(ii).

 

“Suspension
Notice” has the meaning set forth in Section 1(f)(ii).

 

“Suspension
Period” has the meaning set forth in Section 1(f)(i).

 

“Violation”
has the meaning set forth in Section 6(a).

 

“WKSI”
means a “well-known seasoned issuer” as defined under Rule 405. 

 

    	 	A-4	 

     

    

 

EXHIBIT B

 

The undersigned is executing
and delivering this Joinder pursuant to the Registration Rights Agreement dated as of __________________, 20__ (as amended, modified
and waived from time to time, the “Registration Agreement”), among BioScrip, Inc., a Delaware corporation (the
“Company”), and the other persons named as parties therein (including pursuant to other Joinders). Capitalized
terms used herein have the meaning set forth in the Registration Agreement.

 

By executing and delivering
this Joinder to the Company, the undersigned hereby agrees to become a party to, to be bound by, and to comply with the provisions
of, the Registration Agreement as a Holder in the same manner as if the undersigned were an original signatory to the Registration
Agreement, and the undersigned will be deemed for all purposes to be a Holder, an [Investor//Executive//Other Holder thereunder]
and the undersigned’s ____ shares of Common Stock will be deemed for all purposes to be [Investor // Executive //
Other] Registrable Securities under the Registration Agreement.

 

Accordingly, the undersigned
has executed and delivered this Joinder as of the ___ day of ____________, 20___.

 

	 	 
	 	Signature	 
	 	 	 
	 	 
	 	Print Name	 
	 	 	 
	 	Address:	
	 	 
	 	 

 

	Agreed and Accepted as of	 
	 	 
	________________, 20___:	 
	 	 
	BIOSCRIP, INC.	 
	 	 	 
	By:	                   	 
	 	 	 
	Its:	 	 

 

    	 	B-1Exhibit 10.2

 

Execution Version

 

BIOSCRIP,
INC.

 

Director
NOMINATION Agreement

 

THIS Director
NOMINATION Agreement (this “Agreement”) is made and entered into as of August 6, 2019 by and among BioScrip,
Inc., a Delaware corporation (the “Company”), and HC Group Holdings I, LLC, a Delaware limited liability company
(“Investor”). This Agreement will become effective (the “Effective Date”) only upon the issuance
of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at the First Merger Effective
Time, as such term is defined under that certain Agreement and Plan of Merger, dated as of March 14, 2019, by and among the Company,
Investor, HC Group Holdings II, Inc., a Delaware corporation, HC Group Holdings III, Inc., a Delaware corporation, Beta Sub, Inc.,
a Delaware corporation and Beta Sub, LLC, a Delaware corporation (as amended or modified, the “Merger Agreement”).

 

In consideration of
the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, each of the parties to this Agreement agrees as follows:

 

1.           Board
Nomination Rights.

 

(a)          From
the Effective Date until the date that Investor and its Affiliates (as defined below) cease to Beneficially Own shares of Common
Stock representing at least 10% of the total voting power of the then outstanding Common Stock, at every meeting (“Election
Meeting”) of the board of directors of the Company (the “Board”), or a committee thereof, for which
directors of the Company are appointed by the Board or are nominated to stand for election by stockholders of the Company, Investor
shall have the right to nominate for election to the Board, or appoint to fill a vacancy on the Board, as applicable, in each case
in accordance with the Company’s Amended and Restated Bylaws (the “Bylaws”), a number of representatives
equal to the product obtained by multiplying (a) the percentage of the total voting power of the then outstanding Common Stock
then Beneficially Owned by Investor and its Affiliates (the “Investor Voting Control”) and (b) the authorized
number of directors on the Board, including any vacancies, with such product rounded up to the nearest whole number in all cases
(such persons, the “Nominees”). Notwithstanding the foregoing, the number of Nominees at the Effective Date
shall be eight, nothing in this Agreement shall be deemed to modify Section 1.6 of the Merger Agreement and in the event of a conflict
between the provision of this Agreement and the Merger Agreement, the Merger Agreement shall control. “Beneficially Own”
shall have the meaning set forth in Section 13d-3 of the Securities Exchange Act of 1934, as amended. “Affiliate” of
any person shall mean any other person controlled by, controlling or under common control with such person; where “control”
(including, with its correlative meanings, “controlling,” “controlled by” and “under common control
with”) means possession, directly or indirectly, of power to direct or cause the direction of management or policies (whether
through ownership of securities, by contract or otherwise).

 

     

     

    

 

(b)          No
reduction in the number of shares of Common Stock over which Investor retains voting control shall shorten the term of any incumbent
director. At the Effective Date, pursuant to the Merger Agreement, the Board shall be comprised of 10 members and the initial Nominees
shall be Timothy Sullivan, Elizabeth Q. Betten, Nitan Sahney, Harry M. Jansen Kraemer, Jr., John J. Arlotta, John Rademacher, Mark
Vainisi and Alan Nielsen.

 

(c)          In
the event that any Nominee shall cease to serve as a director prior to the end of a term for which it has been duly elected because
of such Nominee’s removal, death, disability, disqualification or resignation from the Board, Investor shall be entitled
to promptly designate such person’s successor in accordance with this Agreement (regardless of the level of Investor Voting
Control at the time of such designation, unless the Investor Voting Control at such time is less than 10% of the total voting power
of the then outstanding Common Stock, in which case the Investor shall have no right to designate a replacement Nominee) and the
Board shall use reasonable best efforts to promptly fill the vacancy with such successor Nominee; it being understood that any
such designee shall serve the remainder of the term of the director whom such designee replaces.

 

(d)          If
a Nominee withdraws as a nominee prior to an Election Meeting or is otherwise unable to stand for election for any other reason
(whether by reason of such person’s death, disability, disqualification or otherwise), Investor shall be entitled to designate
promptly a replacement Nominee prior to such Election Meeting.

 

(e)          If
the size of the Board is expanded, Investor shall be entitled to nominate a number of Nominees to fill the newly created vacancies
such that the total number of Nominees serving on the Board following such expansion will be equal to that number of Nominees that
Investor would be entitled to nominate in accordance with Section 1(a) if such expansion occurred immediately prior to an
Election Meeting, and the Board shall appoint such Nominees to the Board.

 

(f)           The
Company shall use its reasonable best efforts to maintain in effect at all times directors and officers indemnity insurance coverage
on customary and reasonable terms, and the Company’s Amended and Restated Certificate of Incorporation and Bylaws (each as
may be further amended, supplemented or waived in accordance with its terms) shall at all times provide for indemnification, exculpation
and advancement of expenses to the fullest extent permitted under applicable law.

 

(g)          At
such time as the Company ceases to be a “controlled company” and is required by applicable law or the Nasdaq Stock
Market (the “Exchange”) listing standards to have a majority of the Board comprised of “independent directors”
(subject in each case to any applicable phase-in periods), Investor’s Nominees shall include a number of persons that qualify
as “independent directors” under applicable law and the Nasdaq Stock Market (the “Exchange”) listing
standards such that, together with any other “independent directors” then serving on the Board that are not Nominees,
the Board is comprised of a majority of “independent directors”; provided, however, that nothing in this Section 1(g)
shall require the Company to cause John C. Rademacher (or his successor as Chief Executive Officer) to resign from the Board and/or
prevent the Company from nominating John C. Rademacher or the then current Chief Executive Officer for re-election to the Board
after the Company ceases to qualify as a “controlled company” under the rules of the Exchange if serving as Chief Executive
Officer at such time.

 

    	 	2	 

     

    

 

2.          Company
Obligations. The Company agrees to use its reasonable best efforts to ensure that prior to the date that Investor and its Affiliates
cease to Beneficially Own shares of Common Stock representing at least 10% of the total voting power of the then outstanding Common
Stock, (i) each Nominee is included in the Board’s slate of nominees to the stockholders (the “Board’s Slate”)
for each election of directors; and (ii) each Nominee designated by Investor in accordance with this Agreement is included in the
proxy statement prepared by management of the Company in connection with soliciting proxies for every Election Meeting (each, a
“Director Election Proxy Statement”), and at every adjournment or postponement thereof, and on every action
or approval by written consent of the stockholders of the Company or the Board with respect to the election of members of the Board.
The calculation of the number of Nominees that Investor is entitled to nominate to the Board’s Slate for any election of
directors shall be based on the Investor Voting Control immediately prior to the mailing to shareholders of the Director Election
Proxy Statement relating to such election (or, if earlier, the filing of the definitive Director Election Proxy Statement with
the U.S. Securities and Exchange Commission). Unless Investor notifies the Company otherwise prior to the mailing to shareholders
of the Director Election Proxy Statement relating to an election of directors, the Nominees for such election shall be presumed
to be the same Nominees currently serving on the Board, and no further action shall be required of Investor for the Board to include
such Nominees on the Board’s Slate; provided, that, in the event Investor is no longer entitled to nominate the full number
of Nominees then serving on the Board, Investor shall provide advance written notice to the Company, of which currently servicing
Nominee(s) shall be excluded from the Board Slate, and of any other changes to the list of Nominees. If Investor fails to provide
such notice prior to the mailing to shareholders of the Director Election Proxy Statement relating to such election (or, if earlier,
the filing of the definitive Director Election Proxy Statement with the U.S. Securities and Exchange Commission), a majority of
the independent directors then serving on the Board shall determine which of the Nominees of the Investor then serving on the Board
will be included in the Board’s Slate. Furthermore, the Company agrees for so long as the Company qualifies as a “controlled
company” under the rules of the Exchange the Company will elect to be a “controlled company” for purposes of
the Exchange and will disclose in its annual meeting proxy statement that it is a “controlled company” and the basis
for that determination. The Company and Investor acknowledge and agree that, as of the Effective Date, the Company will be a “controlled
company.”

 

3.          Committees.
From and after the Effective Date hereof until such time as Investor and its Affiliates cease to Beneficially Own shares of Common
Stock representing at least 10% of the total voting power of the then outstanding Common Stock, Investor shall have the right to
designate a number of members of each committee of the Board equal to the product obtained by multiplying (a) the Investor Voting
Control and (b) the number of positions, including any vacancies, on the applicable committee with such product rounded up to the
nearest whole number, provided that any such designee shall be a director and shall be eligible to serve on the applicable committee
under applicable law or listing standards of the Exchange, including any applicable independence requirements (subject in each
case to any applicable exceptions for “controlled companies”). Any additional members shall be determined by the Board.
Nominees designated to serve on a Board committee shall have the right to remain on such committee until the next election of directors,
regardless of the level of Investor Voting Control following such designation. Unless Investor notifies the Company otherwise prior
to the time the Board takes action to change the composition of a Board committee, and to the extent Investor has the requisite
Investor Voting Control to nominate a Board committee member at the time the Board takes action to change the composition of any
such Board committee, any Nominee currently designated by the Investor to serve on a committee shall be presumed to be re-designated
for such committee.

 

    	 	3	 

     

    

 

4.          Obligations
of Investor. As a condition to any Nominee’s nomination for election or designation to fill a vacancy as a director of
the Company hereunder, Investor shall (or shall cause the Nominee) promptly upon the request of the Company from time to time and
on or prior to the date specified by the Company in such request, provide to the Company (i) such information as is required to
be disclosed in a Director Election Proxy Statement under applicable law, (ii) an executed consent from the Nominee to be named
as a nominee in the Company’s Director Election Proxy Statement for the applicable stockholder meeting and to serve as a
director if so elected, and (iii) such other information as the Company may reasonably and customarily request.

 

5.          Amendment
and Waiver. Any provision of this Agreement may be amended or waived if, but only if, such amendment or waiver is in writing
and is signed, in the case of an amendment, by the Company and Investor, or in the case of a waiver, by the party against whom
the waiver is to be effective. No failure or delay by any party in exercising any right, power or privilege hereunder shall operate
as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise
of any other right, power or privilege. Investor shall not be obligated to nominate all (or any) of the Nominees it is entitled
to nominate pursuant to this Agreement for any election of directors but the failure to do so shall not constitute a waiver of
its rights hereunder with respect to future elections; provided, however, that in the event Investor fails to nominate
all (or any) of the Nominees it is entitled to nominate pursuant to this Agreement prior to the mailing to shareholders of the
Director Election Proxy Statement relating to such election (or, if earlier, the filing of the definitive Director Election Proxy
Statement with the U.S. Securities and Exchange Commission), the Governance, Compliance and Nominating Committee of the Board shall
be entitled to nominate individuals in lieu of such Nominees for inclusion in the Board’s Slate and the applicable Director
Election Proxy Statement with respect to the election for which such failure occurred and Investor shall be deemed to have waived
its rights hereunder with respect to such election. The rights and remedies herein provided shall be cumulative and not exclusive
of any rights or remedies provided by law.

 

6.         Termination.
This Agreement shall terminate automatically on the date that Investor and its Affiliates, collectively, cease to Beneficially
Own shares of Common Stock representing at least 10% of the total voting power of the then outstanding Common Stock.

 

7.          Benefit
of Parties. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective
permitted successors and assigns. Notwithstanding the foregoing, the Company may not assign any of its rights or obligations hereunder
without the prior written consent of Investor. Nothing herein contained shall confer or is intended to confer on any third party
or entity that is not a party to this Agreement any rights under this Agreement.

 

    	 	4	 

     

    

 

8.          Headings.
Headings are for ease of reference only and shall not form a part of this Agreement.

 

9.          Governing
Law. This Agreement shall be construed in accordance with and governed by the law of the State of Delaware without giving effect
to the principles of conflicts of laws thereof.

 

10.         Jurisdiction.
Any suit, action or proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection with,
this Agreement may be brought against any of the parties in any federal court located in the State of Delaware or any Delaware
state court, and each of the parties hereby consents to the exclusive jurisdiction of such court (and of the appropriate appellate
courts) in any such suit, action or proceeding and waives any objection to venue laid therein. Process in any such suit, action
or proceeding may be served on any party anywhere in the world, whether within or without the jurisdiction of any such court. Without
limiting the foregoing, each of the parties agrees that service of process upon such party at the address referred to in Section
17, together with written notice of such service to such party, shall be deemed effective service of process upon such party.

 

11.         WAIVER
OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING
ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT.

 

12.         Entire
Agreement. With the exception of the Merger Agreement, this Agreement constitutes the entire agreement among the parties with
respect to the subject matter hereof and supersedes all prior agreements (other than the Merger Agreement), understandings and
negotiations, both written and oral among the parties with respect to the subject matter hereof.

 

13.         Counterparts;
Effectiveness. This Agreement may be signed in any number of counterparts, each of which shall be deemed an original. This
Agreement shall become effective when each party shall have received a counterpart hereof signed by each of the other parties.
An executed copy or counterpart hereof delivered by facsimile shall be deemed an original instrument.

 

14.         Severability.
If any provision of this Agreement or the application thereof to any person or circumstance shall be invalid or unenforceable to
any extent, the remainder of this Agreement and the application of such provisions to other persons or circumstances shall not
be affected thereby and shall be enforced to the greatest extent permitted by law.

 

15.         Further
Assurances. Each of the parties hereto shall execute and deliver such further instruments and do such further acts and things
as may be reasonably required to carry out the intent and purpose of this Agreement.

 

    	 	5	 

     

    

 

16.         Specific
Performance. Each of the parties hereto agrees that irreparable damage may occur if any provision of this Agreement were not
performed in accordance with the terms hereof and that the parties shall be entitled to seek an injunction or injunctions to prevent
breaches of this Agreement or to enforce specifically the performance of the terms and provisions hereof in any federal or state
court located in the State of Delaware, in addition to any other remedy to which they are entitled at law or in equity.

 

17.         Notices.
All notices, requests and other communications to any party or to the Company shall be in writing (including telecopy, e-mail or
similar writing) and shall be given,

 

If to the Company:

 

BioScrip, Inc.

1600 Broadway, Suite 700

Denver, CO 80202

Attention: General Counsel

 

With a copy to (which shall not constitute notice):

 

Gibson, Dunn &
Crutcher, LLP

200 Park Avenue

New York, NY 10166

Attention: Sean P.
Griffiths

 

If to any member
of Investor or any Nominee:

 

c/o HC Group Holdings
I, LLC

c/o Madison Dearborn
Partners, L.L.C.

70 W. Madison St.

Suite 4600

Chicago, Illinois 60602

Attention: General
Counsel

 

With a copy to (which
shall not constitute notice):

 

Kirkland & Ellis
LLP

300 N. LaSalle

Chicago, IL 60654

Attention: Sanford
E. Perl, P.C.

    Mark A. Fennell,
P.C.

 

or to such other address or telecopier
number as such party or the Company may hereafter specify for the purpose by notice to the other parties and the Company. Each
such notice, request or other communication shall be effective when delivered at the address specified in this Section 17
during regular business hours.

 

    	 	6	 

     

    

 

18.         Enforcement.
Each of the parties hereto covenant and agree that the disinterested members of the Board have the right to enforce, waive or take
any other action with respect to this Agreement on behalf of the Company.

 

*         *         *         *         *

 

    	 	7	 

     

    

 

IN WITNESS WHEREOF, the parties hereto
have executed this Agreement on the date first above written.

 

	 	BIOSCRIP, INC.
	 	 	 
	 	By:	/s/ Daniel Greenleaf
	 	 	Name: Daniel E. Greenleaf
	 	 	Title: President
	 	 	 
	 	HC GROUP HOLDINGS I, LLC
	 	 	 
	 	By:	/s/ Clifford Berman
	 	 	Name: Clifford Berman 
	 	 	Title: Corporate Secretary

 

[BioScrip - Director Nomination Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}]]